Development of a modeling framework to simulate efficacy endpoints for motesanib in patients with thyroid cancer. (Q42876181)
Jump to navigation
Jump to search
scientific article published on 25 September 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Development of a modeling framework to simulate efficacy endpoints for motesanib in patients with thyroid cancer. |
scientific article published on 25 September 2010 |
Statements
Development of a modeling framework to simulate efficacy endpoints for motesanib in patients with thyroid cancer (English)
Laurent Claret
Jian-Feng Lu
25 September 2010